| OUR PUBLICATIONS |
Haberman Associates' publications
are designed to help you understand and act on the ever-changing science,
technology, market, and strategic issues that affect the life science industry.
They also help you assess leading companies and their products and technologies.
Our publications include in-depth research and analysis in:
Business strategy in the pharmaceutical, biotechnology, and life science
industry
R&D strategy
Therapeutic area and pipeline strategy
Technology assessment
We apply similar types of research and analysis as in our publications to our consulting engagements. However, our consulting engagements focus on your company's specific issues, and on developing executable recommendations for action in collaboration with you and your colleagues.
Organizations that publish our books and reports include Cambridge
Healthtech Institute, Decision
Resources, Emirates Center for Strategic
Studies and Research (ECSSR) and Informa
Healthcare (the parent company of
Scrip,
Clinica,
and PharmaProjects).
We also produce articles that have appeared in such leading publications
as Genetic Engineering News, Pharma DD, and PharmaWeek.
See our home page
for examples.
For information on our recent major publications, or to order them, please
click on the following links:
Blood-Brain
Barrier: Bridging Options for Drug Discovery and Development. May
9, 2008. Allan B. Haberman, Ph.D. Published
by Cambridge Healthtech Institute.
Diabetes and Its Complications: Strategies to Advance Therapy and Optimize
R&D. April 27, 2007. Allan
B. Haberman, Ph.D. Published by Cambridge Healthtech Institute.
Emerging Targets in Diseases with High Unmet Need: Alzheimer’s Disease,
Lung Cancer, Dyslipidemia, Type 2 Diabetes, and COPD. June
23, 2006. Allan B. Haberman, Ph.D. Published by Cambridge Healthtech Institute.
Powering
Drug Discovery through Target Evaluation: Moving Beyond the Validation
Paradigm. August 18, 2005. Allan
B. Haberman, Ph.D. Published by Cambridge Healthtech Institute.
“Biotechnology
and the Future of the Pharmaceutical Industry”. Allan
B. Haberman, Ph.D. In Biotechnology and the Future of Society:
Challenges and Opportunities, Emirates Center for Strategic Studies
and Research (ESCCR), distributed by I.B. Tauris, June 2004.
Available from the following sources:
Amazon.com
Barnes
& Noble
IB
Tauris
The
Emirates Center for Strategic Studies and Research
From Data to Drugs: Strategies for Benefiting from New Drug Discovery Technologies.
July 1999. Allan B. Haberman, Ph.D., George R. Lenz, Ph.D., and Dennis
E. Vaccaro, Ph.D. Published by PJB Publications Ltd. (Scrip Reports).
Home Page |
About Haberman Associates |
About Allan B. Haberman |
Speaking |
News Page |
Contact us| |Site
map